The Lancet Microbe

SJR Rank #269H-index: 67SJR: 5.192Best quartile: Q1Open AccessAPC: US$7,280Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

20222025036912

Subject Categories

  • Infectious DiseasesQ1
  • MicrobiologyQ1
  • Microbiology (medical)Q1
  • VirologyQ1

Areas: Immunology and Microbiology · Medicine

Most published research topics

SARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceTuberculosis Research and EpidemiologyViral Infections and Outbreaks ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections researchSARS-CoV-2 detection and testingBacterial Identification and Susceptibility TestingZoonotic diseases and public health

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025065130195260

Detailed Information

ISSN

2666-5247

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

9.54

References per Document

28.06

Coverage

2020-2026

Scope

The Lancet Microbe publishes clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology). We also publish early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen. The journal also continues in the The Lancet's tradition of being a strong advocate for and collaborator with the community we serve. We publish a range of content types including Articles, Comment, Correspondence, Newsdesk, and Personal View.

Metrics from SCImago Journal Rank 2025. View on SCImago